XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (17,910,210) $ (11,533,356) $ (58,253,723) $ (30,108,680)
Adjustments to reconcile comprehensive loss to net cash used in operating activities:        
Stock-based compensation 1,125,209 3,058,741 3,420,664 4,508,474
Depreciation and amortization 3,027,644 2,887,244 3,938,860 1,501,826
Common stock issued in exchange for professional services     2,907,000
Paycheck Protection Program loan forgiveness     (108,532)
Provision for inventory obsolescence     305,399
Loss on disposal of fixed assets     25,960 3,712
Defined benefit plan obligation (188,653) (148,851) (215,797) (17,691)
Amortization on debt discount 612,712 46,270
Gain on debt extinguishment 1,523,867 (6,486,899) (6,463,101)
Goodwill impairment 1,500,000 41,687,871 12,357,921
Lease impairment 79,287    
Changes in assets and liabilities:        
Accounts receivable, net 223,208 (396,617) 637,156 514,265
Inventories, net 660,208 (2,221,569) (2,605,028) (1,981,952)
Prepaid expenses and other assets 237,815 22,579 230,688 (218,493)
Accounts payable 264,123 (281,937) (681,556) 552,741
Accrued expenses and other liabilities (28,133) (193,818) (716,960) (2,892,728)
Contract liabilities (169,352) (307,610) (472,604) 393,521
COVID loan     (345,484) (179,910)
Other 212,606 433,357 (340,886)
Net cash used in operating activities (8,829,669) (15,168,736) (20,107,670) (12,463,127)
CASH FLOW FROM INVESTING ACTIVITIES:        
Payment on notes receivable     315,000
Acquisition of MicaSense, net of cash acquired     (3,645,911) (14,568,897)
Acquisition of Measure, net of cash acquired     (14,916,850)
Acquisition of senseFly, net of cash acquired     (2,964,989) (11,425,493)
Purchases of fixed assets (95,004) (250,379) (313,769) (525,312)
Payment of acquisition-related liabilities (6,610,900)    
Platform development costs (297,596) (635,568) (817,029) (1,097,808)
Internal use software costs (171,516) (565,894) (618,061) (278,264)
Net cash used in investing activities (564,116) (8,062,741) (8,359,759) (42,497,624)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Sales of Common Stock, net of issuance costs 3,817,400 4,583,341 4,583,341 37,182,646
Sale of Common Stock from exercise of warrants     8,305,368
Sale of Preferred Stock, Series F Convertible, net of issuance costs 3,000,000 9,920,000 9,920,000
Promissory note     3,285,000
Exercise of stock options 74,350 74,350 122,970
Repayments on COVID loans (87,052) (173,313)    
Net cash provided by financing activities 6,730,348 14,404,378 17,862,691 45,610,984
Effects of foreign exchange rates on cash flows (86,257) (460,980) 364,009
Net decrease in cash (2,749,694) (9,288,079) (10,240,729) (9,349,767)
Cash at beginning of year 4,349,837 14,590,566 14,590,566 23,940,333
Cash at end of year 1,600,143 5,302,487 4,349,837 14,590,566
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest cash paid 7,590
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Conversion of Preferred Stock, Series F Convertible to Common Stock 7,305 5,950 6,805
Issuance of restricted Common Stock 388 316 483
Dividends on Series F Preferred Stock 170,277 94,694 172,596
Deemed dividend on Series F Preferred stock 4,910,894 2,245,377
Stock consideration for the senseFly Acquisition 3,000,000 3,000,000
Settlement of Common Stock from contingent liability related to Measure $ 2,812,500 2,812,500
Acquisition liability related to the MicaSense Acquisition     5,000,000
Stock consideration for the MicaSense Acquisition     3,000,000
Acquisition liability related to the Measure Acquisition     5,625,000
Stock consideration for the Measure Acquisition     $ 24,375,000